Deepening India–US Biotech Collaboration
Dr. Singh emphasized that science, technology, and biotechnology are critical pillars of the India–US comprehensive strategic partnership. Highlighting India’s strengths as a global hub for biotech and pharmaceutical innovation, he outlined the country’s robust research and manufacturing capabilities spanning R&D, process development, and cost-efficient production.
Proposed Areas of Cooperation
The Minister highlighted potential collaboration in advanced biomanufacturing, AI-enabled production processes, rapid scale-up technologies, and next-generation biologics and vaccines. He suggested leveraging India’s cost-efficient manufacturing with Delaware’s proximity to major US pharmaceutical companies for co-developing affordable biologics, biosimilars, and vaccines for global health needs.
Key cooperation areas include joint advanced biomanufacturing platforms, translational research bridges linking Indian institutions and Delaware centers, startup incubation linkages, and workforce co-training in GMP manufacturing, regulatory science, and quality systems. Regulatory alignment and resilient supply chains for critical biopharmaceutical inputs were also emphasized.
Leveraging Innovation Ecosystems
Dr. Singh mentioned that India’s Ministry of Science and Technology supports around 150 incubators across academic institutions and universities. He also cited the ₹1 lakh crore research, development, and innovation fund, which could be leveraged to engage Delaware’s research, manufacturing, and startup ecosystem.
Governor Meyer acknowledged Delaware’s science and industrial heritage, highlighting its bio-pharmaceutical manufacturing base, expanding port infrastructure, and business-friendly environment. Discussions covered clean hydrogen, workforce development, startup incubation, and corporate incorporation frameworks.
Next Steps and Strategic Significance
Both sides agreed on a structured working group mechanism to convert discussions into actionable programs, including joint research calls, startup exchanges, and institutional partnerships. This engagement adds a state-level dimension to the India–US strategic partnership, with biotechnology and advanced manufacturing prioritized for the next phase of cooperation.
